FDA’s Preliminary Evaluation Suggests No Increased Risk of Suicidal Ideation With Weight-loss Drugs A follow-up on last week's coverage of this evolving topic
FDA Investigating Reports of Serious Complications With Semaglutide (Ozempic) and Related Weight-loss Drugs Suicidal ideation, aspiration, and alopecia added to the list as new safety concerns
Ayizo Biologics Recalls Its Viable Bone Matrix Products Company recalls product after two patients develop M. tuberculosis